0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Obituary |

John Newsom-Davis, MD (1932-2007) FREE

Lewis P. Rowland, MD
Arch Neurol. 2007;64(12):1796. doi:10.1001/archneur.64.12.1796.
Text Size: A A A
Published online

John Newsom-Davis died in an automobile accident on August 24, 2007, while he was on vacation in Romania. His wife of 44 years, Rosemary, was seriously injured but survived. So ends the career of one of the most productive of all modern research neurologists.

Place holder to copy figure label and caption

John Newsom-Davis, MD. (We express our gratitude to Professor Angela C. Vincent, University of Oxford, for providing the photograph.)

Graphic Jump Location

Newsom-Davis came late to medicine; he was delayed because he was piloting jet fighters in the Royal Air Force in 1951 to 1953. In 1954 he entered Cambridge University, where he played varsity hockey; he received a BA degree in 1957. He then enrolled in the Middlesex Hospital Medical School, where he gained his MD in 1966. He was a house physician at the National Hospital for Neurology and Neurosurgery (Queen Square) from 1966 to 1968. After coming to New York for research training with Fred Plum, Newsom-Davis' first papers were about pulmonary function in health and disease. For the next decade, he was a consultant neurologist at Queen Square and the Royal Free Hospital. In 1980, he was made MRC Clinical Research Professor of Neurology, and in 1987, he became professor of clinical neurology at Oxford. There, with Angela Vincent, he established a myasthenia gravis unit, where he worked for the next 11 years. He continued as professor and honorary consultant until his retirement in 1998.

John Newsom-Davis' first contribution to myasthenia research, with Anthony Pinching and Keith Peters, showed the dramatic effect of plasmapheresis. Vincent was a coauthor on almost all of Newsom-Davis' papers on autoimmune diseases, and together they documented the therapeutic value of plasmapheresis and the pathogenic effects of antibody to the acetylcholine receptor. In 1980, with Alastair Compston, they reported that combinations of HLA antigens, clinical findings, and antibody status demonstrated clinical heterogeneity. The next year, they found that the antibodies were formed in the thymus and that antibody receptors were present on muscle-like cells in the thymus. They tackled the question of “seronegative” myasthenia, the patients who lacked anti–AChR in about 15% of all cases. Ultimately they identified antibodies to muscle-specific kinase in about half of that group. They noted atrophy of facial muscles in the MuSK cases and provided evidence that this was a fixed myopathy.

Dr Newsom-Davis' interest in myasthenia and his leadership qualities were evident even at the end of his life. He was called to lead a randomized controlled therapeutic trial of thymectomy that was international in multicenter scope but based and funded in the United States.

Newsom-Davis and his growing team members also worked on other autoimmune diseases, including Lambert-Eaton myasthenic syndrome (which they found was caused by IgG antibodies to nerve terminal voltage-gated calcium channels, detectable in more than 90% of patients). They also identified antibodies to voltage-gated potassium channels (VGKCs) in about 40% of patients with peripheral nerve hyperexcitability in the syndrome called neuromyotonia and even in some people with the more common cramp-fasciculation syndrome. The same VGKC antibodies were found in a syndrome of cognitive decline and muscle fasciculation (Morvan syndrome) and also in limbic encephalitis. These syndromes were sometimes but not always paraneoplastic.

Newsom-Davis and his colleagues were leaders in the study of nonimmune congenital forms of myasthenia, demonstrating that they were heterogeneous and not autoimmune. They identified 1 form with proximal limb muscle weakness and autosomal-recessive mutations in the gene for Dok7, resulting in a defective structure of the neuromuscular junction.

Honors came aplenty: fellow of the Royal Society; Association of British Neurologist Medal; editor of Brain, 1997-2004; Medical Research Council, 1980-1992; vice president, International Society for Neuroimmunology, 1987-1995; Commander of the British Empire, 1996; and honorary member of the United States Institute of Medicine, American Neurological Association, and American Academy of Neurology.

His lectures were always memorable. The president of the Australian Association of Neurologists commented, “That was the best lecture in clinical neurology I ever heard—real bonzer.” In Australia, bonzer is a slang adjective meaning extraordinarily first-rate.

To those who had the true privilege of knowing him personally, Dr Newsom-Davis was warm, considerate, thoughtful, and witty. He is survived by his wife, Rosemary, a twin sister, and 3 children.

ARTICLE INFORMATION

Correspondence: Dr Rowland, Neurological Institute, Columbia University Medical Center, 710 W 168th St, Box 147, New York, NY 10032-2603 (lpr1@columbia.edu).

Figures

Place holder to copy figure label and caption

John Newsom-Davis, MD. (We express our gratitude to Professor Angela C. Vincent, University of Oxford, for providing the photograph.)

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

576 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs
JAMAevidence.com

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Accuracy of Clinical Findings in Endemic Areas

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Data Analysis and Statistical Methods